openPR Logo
Press release

Molecular Diagnostics Market - Global Industry Insights

05-05-2018 01:13 PM CET | Health & Medicine

Press release from: Clinical Diagnostic Market Report

Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA, which may be associated with disease. The disturbance between a single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others factors lead to various diseases. Disease that are diagnosed by using molecular diagnostic test includes infectious diseases, oncology, virology, and STDs.

Increasing incidence and prevalence of infectious disease and cancer is expected to be a major factor for growth of the market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, around 5,251 deaths were reported due to influenza infection in the U.S. Furthermore, according to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S. with an estimated 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1545

Molecular diagnostics also helps in providing precision medicine, due to capability of detecting specific disease. Therefore, various governments are focusing on initiatives in precision medicine, which is expected to foster growth of the molecular diagnostics market in the near future. For instance, in 2015, the U.S. government launched Precision Medicine Initiative (PMI), to increase awareness regarding advancement in the precision medicine field.

The molecular diagnostics market is estimated to be valued at US$8,623.2 Mn in 2017 and is expected to witness a robust CAGR of 11.5% during the forecast period (2017-2025).

Growth in biomarker identification is expected to foster growth of the molecular diagnostics market

Application of biomarkers in molecular diagnostic is increasing, due to advantages of biomarkers such as aiding in early detection of specific diseases. For instance, biomarkers are used in detection of ABO haemolytic diseases in new born, Huntington's disease and hereditary haemochromatosis, and cystic fibrosis. Biomarkers are also used in detection of disorders related to chromosome structure such as Turner syndrome, Down syndrome, patau syndrome, and Edwards’s syndrome. Furthermore, biomarker also have wide application in therapeutic areas, which includes neurological diseases, metabolic disorders, immune deregulation, and oncology.

Increasing research and development for identification of biomarkers have led to development of new molecular diagnostic tests, which is expected to foster growth of the molecular diagnostics market. For instance, in February 2018, FDA granted marketing authorization to Banyan Biomarkes, Inc. for the first diagnostic blood test, for traumatic brain injury, Banyan BTI. Such innovations for various disease indication is expected to drive growth of the molecular diagnostics market in the near future.

Regional insights

North America accounts for the largest share in the global molecular diagnostics market and this is attributed to increasing adoption of precision medicine and growing prevalence of cancer. According to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024, in turn increasing the demand of the molecular diagnostics market in the near future.

Furthermore, the U.S. government, in 2015, launched Precision Medicine Initiative that aimed to revolutionize the treatment to improve health, as precision medicine provides an innovative approach that takes into account an individual’s differences in genes and offers tailored treatment. Precision Medicine Initiative have led to development of novel products and several new treatments are tailored for specific characteristic such as, person’s genetic makeup or genetic profile of an individual tumor that helps to transform the way of treatment. The Precision Medicine Initiative was valued at US$ 215 million in 2016 that could accelerate biomedical research and provide clinicians with new tools to select the innovative therapies tailored according to individual needs that, in turn favors, growth of the market of molecular diagnostic.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1545

Key players in the market are involved in new product launches to cater to increasing demand for molecular diagnostic. For instance, in August 2016 Abbott Laboratories introduced Alinity, a next generation system, used for immunoassay, clinical chemistry, point-of-care, hematology, blood and plasma screening, and molecular diagnostics. Some of the other key players in the global molecular diagnostics market include Hologic,Inc., Grifols, S.A., Abbott Laboratories, Qiagen N.V., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, and Beckman Coulter, Inc.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Molecular Diagnostics Market - Global Industry Insights here

News-ID: 1040470 • Views: 634

More Releases from Clinical Diagnostic Market Report

Women’s Health Diagnostic Test Market - By Application Ovarian Cancer Test, Br …
In 2017, Naugatuck Valley Women’s Health Specialists (NVWHS) decided to provide a free informational program for heart health with Boston Heart Diagnostics. Boston Heart diagnostics has anticipating treatment and diagnosis of cardiovascular diseases (CVD), which improves women’s heart health, as CVD is a leading disease in the U.S. This program is expected to create awareness of CVD related diseases among women and also help to improve lifestyle. Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/971
Non-Invasive Cancer Diagnostics Market- Trends And Outlook
Non-invasive cancer diagnostics are procedures used for the identification of cancer without incision in the body. Detection and treatment of cancer at early stages are important for long-term survival. Non-invasive cancer detection method is found to be an increasing choice of interest, owing to its painless or minimal pain method of diagnostic coupled with more accurate results. Molecular based diagnostic methods are expected to increase during the forecast period due
Autoimmune Disease Diagnostics Market - Global Industry Insights, Trends, 2017 …
The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. The autoimmune disease causes abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the
Enteric Disease Testing Market - Global Industry Insights, Trends 2017–2025
Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five

All 5 Releases


More Releases for Precision

Precision Medicine Market
Precision medicine is an approach of treatment that has been derived on the basis of individual variability in environment, genes and lifestyle of each person. This novel approach assists medical practitioners and researchers to understand various treatment needs in order to prevent specific diseases. It allows for highly precise targeting of medication for treatment of various diseases, which is expected to lead to high adoption by medical practitioners and researchers.
High Precision Linear Positioners
A large variety of high precision linear positioners, XY stages and vertical linear stages is offered by PI miCos. These highly accurate systems are available with many different drive options from stepper motors to rotary servo motors and electromagnetic linear motors. Miniature stages with piezo motors are also offered. Applications for these linear motion systems include semiconductor test equipment, photonics alignment, lab-automation, bio-nanotechnology, beam line instrumentation, aerospace technology,
High Precision in Six Axes
The H-811 miniature Hexapod from PI (Physik Instrumente) has very compact dimensions with a diameter of only 130 mm and a height of 115 mm. In addition to the vacuum version, it is now also available in an air version. The H-811 offers travel ranges of up to 35 mm in the XY level and up to 13 mm in the Z direction. It is especially the large tilting angles
Ceramic Drivers for Higher Precision
Piezo stepping drives replace the usual stepper or DC motors in the linear actuators of the N-381 series from Physik Instrumente (PI). As a direct linear drive the stepping drive is free of precision losses due to the exchange from rotational to linear motion. The N-381 can be operated at a velocity of 10 mm/s, provides resolutions of 20 nanometers, the position is measured using an integrated linear encoder. The
Precision without Position Sensor
Phase shifters are used in laser measurement to align optical path lengths. These move optics in the range of a wavelength, which corresponds to an adjustment range of less than one micrometer. It is crucial for the alignment to take place quickly and in a stable manner. For the new S-303.BL phase shifter, PI (Physik Instrumente) replaces classic piezo ceramic PZT actuators (made of lead titanate - lead zirconate) with pico
Perfectly Aligned Precision
With the new N-664 linear positioning stage, PI (Physik Instrumente) has succeeded in developing a further groundbreaking piezo positioning system of the reference class. A NEXACT® piezo linear drive replaces the usual stepper or DC servo motor in the N-664, thus making a position resolution of far less than a nanometer possible. Aligned to it is the new PIOne optical linear encoder with a resolution of 0.5 nm, which allows for